Scarica l'app Stockscreener
366.21
0.43%
-1.58
Dopo l'orario di chiusura:
366.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$367.79
Aprire:
$370.68
Volume 24 ore:
1.49M
Relative Volume:
0.54
Capitalizzazione di mercato:
$197.41B
Reddito:
$36.74B
Utile/perdita netta:
$7.71B
Rapporto P/E:
25.73
EPS:
14.2333
Flusso di cassa netto:
$8.10B
1 W Prestazione:
-0.90%
1M Prestazione:
-0.81%
6M Prestazione:
+32.50%
1 anno Prestazione:
+17.13%
Intervallo 1D:
$365.93
$372.98
Intervallo di 1 settimana:
$365.93
$380.14
Portata 52W:
$261.43
$391.29
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
366.21 | 197.41B | 36.74B | 7.71B | 8.10B | 14.23 |
|
LLY
Lilly Eli Co
|
985.08 | 879.67B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
241.52 | 582.04B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
219.68 | 388.43B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
189.90 | 294.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
153.44 | 292.79B | 54.72B | 14.02B | 15.32B | 7.1855 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Iniziato | Jefferies | Hold |
| 2026-02-20 | Iniziato | Barclays | Equal Weight |
| 2026-01-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Amgen (AMGN) and GSK (GSK) Expand Reach with TrumpRx Partnership - GuruFocus
Amgen and GSK said to be adding products on TrumpRx - Seeking Alpha
Amgen Inc. Stock (ISIN: US0311621009) Gains Defensive Appeal Amid Leadership Shift and Biotech Resil - AD HOC NEWS
M&T Bank Corp Trims Position in Amgen Inc. $AMGN - MarketBeat
Harvest Fund Management Co. Ltd Sells 4,234 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock Dips Amid TrumpRx Partnership News as Valuation Stands Firm - AD HOC NEWS
Comerica Bank Has $46.70 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Capital Wealth Planning LLC Sells 472,530 Shares of Amgen Inc. $AMGN - MarketBeat
GSK and Amgen to add medicines to TrumpRx, Fox Business reports - Reuters
Sandoz Appealing Ruling Over Amgen's Enbrel Biosimilar - Law360
Amgen obtains EPA ENERGY STAR 2025 certification - WJournalpr
Amgen Inc. Stock (ISIN: US0311621009) Hits Defensive Strength Amid Biotech Shifts - AD HOC NEWS
Starbucks, Amgen, CVS and Other Stocks Help This Income Fund Shine - Barron's
Amgen vs Sanofi – A chronology of the patent battle over Repatha and Praluent - JUVE Patent
Amgen Inc. $AMGN Shares Sold by Martingale Asset Management L P - MarketBeat
Invesco Ltd. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Mackenzie Financial Corp - MarketBeat
Amgen Inc. $AMGN Shares Bought by American Investment Services Inc. - MarketBeat
Advisory Research Inc. Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Amgen and Sanofi end epic battle over Praluent and Repatha - JUVE Patent
Is It Time To Reassess Amgen (AMGN) After Its Strong 1 Year Share Price Run? - simplywall.st
Amgen: MariTide And Osteoporosis Sales Fuel The Rally (NASDAQ:AMGN) - Seeking Alpha
SevenBridge Financial Group LLC Decreases Position in Amgen Inc. $AMGN - MarketBeat
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN - MarketBeat
Inceptionr LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference - MarketBeat
Kepler Cheuvreux Suisse SA Makes New $5 Million Investment in Amgen Inc. $AMGN - MarketBeat
Anti Oral Mucositis Drug Market Is Booming So Rapidly | Amgen • Merck & Co. Inc. • Bristol-Myers Squibb - openPR.com
Amgen Inc. $AMGN Stock Holdings Decreased by Richard Bernstein Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by Russell Investments Group Ltd. - MarketBeat
Bank of Montreal Can Raises Stake in Amgen Inc. $AMGN - MarketBeat
Amgen further shrinking Montgomery County footprint, cutting 22 positions - The Business Journals
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.
Forecasting The Future: 15 Analyst Projections For Amgen - Benzinga
Van ECK Associates Corp Purchases 567,400 Shares of Amgen Inc. $AMGN - MarketBeat
Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More - 24/7 Wall St.
Amgen Inc. $AMGN Stock Holdings Lifted by Capital Research Global Investors - MarketBeat
Capital International Ltd. CA Has $15.75 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital World Investors Acquires 1,935,876 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Sarl Purchases 46,052 Shares of Amgen Inc. $AMGN - MarketBeat
Capital International Investors Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Capital International Inc. CA Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Boosted by Legal & General Group Plc - MarketBeat
Capital Group Investment Management PTE. LTD. Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Capital Group Private Client Services Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Assessing Whether Amgen (AMGN) Shares Look Mispriced After Recent Mixed Returns - Yahoo Finance
Jefferies initiates Amgen stock with hold rating on pipeline risk - Investing.com
Amgen Inc. $AMGN Shares Purchased by Schroder Investment Management Group - MarketBeat
Amgen Inc.: Close to a key resistance level - marketscreener.com
Crysvita Market Is Going to Boom | Kyowa Kirin • Amgen • Sanofi • Takeda Pharmaceutical - openPR.com
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):